Today,
shortly after the opening bell, VolitionRx announced that it has engaged the
investor relations services of MissionIR. Through a network of
investor-oriented sites and full suite of investor awareness services,
MissionIR broadens the influence of publicly traded companies and enhances
their ability to attract growth capital as well as improve shareholder value.
“VolitionRx
is developing a blood-based cancer diagnostics tool that in preclinical trials
has demonstrated tremendous potential to change the landscape of colorectal
cancer screening,” stated Sherri Franklin, Director of Marketing at MissionIR.
“As the Company continues its focus on ongoing clinical trials of this product,
MissionIR will work to increase VolitionRx’s visibility among the investment
community and strengthen dialogue with existing Company shareholders. We’re
excited to be a part of VolitionRx’s future.”
Cameron
Reynolds, CEO of VolitionRx, stated, “This new partnership with MissionIR will
enhance our current investor relations initiatives and help us to execute a
strategic campaign to better reach and communicate with our shareholders.
Additionally, as we continue with the advancement of our cancer diagnostic
tests, we look forward to working with MissionIR’s team to maximize product
exposure and attain our short-term and long-term goals. MissionIR is providing
a much needed service not only to VolitionRx, but to the broader small-cap
market.”
VolitionRx
is a life sciences company focused on developing blood-based diagnostic tests
for different types of cancer. The tests are based on the science of
Nucleosomics which is the practice of identifying and measuring nucleosomes in
the bloodstream — an indication that cancer is present. VolitionRx’s goal is to
make the tests as common and simple to use, for both patients and doctors, as
existing diabetic and cholesterol blood tests.
For
more information on VolitionRx, visit http://VNRX.MissionIR.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
